Jeffrey L. Alvaro, M.D., introduces an upcoming panel discussion surrounding the clinical implications of novel drug delivery systems in the management of Pediatric ADHD, utilizing 3 patient cases.
Clinical Considerations and Implication of Novel Drug Delivery Systems for the Management of Pediatric ADHD
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Transforming teen obesity care: How integrated specialty pharmacy models expand GLP-1 access
2
Redefining type 1 diabetes: Early identification, staging, and clinical implications for pediatric care
3
Daniele De Luca, MD, discusses zelpultide alfa in neonates at high risk of bronchopulmonary dysplasia development
4
CDC updates website, opens door for autism and vaccines link
5
